Prevena Therapy for Spine Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a special bandage that uses suction to help wounds heal faster in patients having spine surgery. The goal is to see if it can prevent infections and other problems better than regular bandages. The study will also find out which patients benefit the most from using this device.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
How does Prevena Therapy for Spine Surgery differ from other treatments?
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are having spine surgery and need a plastic surgeon to close the wound. They must have a risk score of 80 or above, indicating they're at higher risk for complications. Pregnant individuals, those with low-risk scores, or with conditions that could affect study results or compliance can't participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo spine surgery and receive either Prevena or conventional wound dressing
Follow-up
Participants are monitored for surgical site infections, wound dehiscence, seroma, skin necrosis, and readmission
What Are the Treatments Tested in This Trial?
Interventions
- Prevena Spine
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
3M
Industry Sponsor
Dr. John Banovetz
3M
Chief Medical Officer since 2017
PhD in Inorganic Chemistry from Stanford University, Bachelor's degree in Chemistry from Hamline University
William 'Bill' Brown
3M
Chief Executive Officer
Bachelor's and Master's degrees in Mechanical Engineering from Villanova University, MBA from The Wharton School, University of Pennsylvania